[Federal Register Volume 88, Number 212 (Friday, November 3, 2023)]
[Presidential Documents]
[Pages 75455-75456]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24488]




                        Presidential Documents 



Federal Register / Vol. 88, No. 212 / Friday, November 3, 2023 / 
Presidential Documents

[[Page 75455]]


                Proclamation 10662 of October 31, 2023

                
National Alzheimer's Disease Awareness Month, 
                2023

                By the President of the United States of America

                A Proclamation

                Over six million Americans live with Alzheimer's 
                disease, a form of dementia that deprives people of 
                their precious memories, thoughts, and identity. During 
                National Alzheimer's Disease Awareness Month, we honor 
                the extraordinary courage, strength, and resilience of 
                people facing this devastating disease. We recognize 
                the support of families and caregivers who stand by 
                their loved one's side and help them age with dignity. 
                We resolve to continue advancing scientific research 
                and treatment options to ensure a brighter future for 
                all Americans facing Alzheimer's.

                Today, Alzheimer's remains a leading cause of death in 
                older adults. It exacts an emotional, physical, and 
                financial toll on the entire family of those who are 
                diagnosed--especially for African Americans and 
                Latinos, who are more likely to develop dementias than 
                any other races or ethnicities, and for individuals 
                with Down syndrome, who are at higher risk for 
                Alzheimer's. My Administration has taken numerous 
                actions to help treat and prevent this terrible 
                disease. We worked with the Congress to secure $2.5 
                billion in bipartisan funding for the Advanced Research 
                Projects Agency for Health (ARPA-H). This agency is 
                developing critical breakthroughs in preventing, 
                diagnosing, and treating Alzheimer's and other deadly 
                diseases and pioneering partnerships to get those 
                breakthroughs out to clinics and patients.

                Earlier this year, the Food and Drug Administration 
                granted the first-ever approval for a prescription drug 
                that can alter the course of Alzheimer's in some 
                people, rather than simply treat symptoms--a sign of 
                hope to so many patients and families affected by this 
                disease. In addition, I was proud to sign an Executive 
                Order on Increasing Access to High-Quality Care and 
                Supporting Caregivers. As a result, the Centers for 
                Medicare and Medicaid Services (CMS) announced a 
                groundbreaking model that will offer a comprehensive 
                package for care management and coordination for people 
                living with Alzheimer's and related dementias, 
                caregiver support and education, and respite services. 
                Meanwhile, CMS continues to offer services that help 
                people access cognitive care assessments, ensuring that 
                those with Alzheimer's receive the care they need. In 
                addition, the Centers for Disease Control and 
                Prevention is creating a uniform national public health 
                infrastructure focused on increasing early detection 
                and diagnosis of Alzheimer's disease and related 
                dementias, reducing dementia risk, preventing avoidable 
                hospitalizations, and supporting caregivers of those 
                living with dementia.

                This November, let us honor the memory of those we have 
                tragically lost to Alzheimer's. Let us recognize the 
                millions of Americans who are living with the impact of 
                this condition every day and all the incredible 
                caregivers, doctors, researchers, and advocates 
                supporting them. Let us come together as a Nation; 
                carry forward a spirit of hope; and recommit to doing 
                everything we can to prevent, treat, and eliminate this 
                disease.

                NOW, THEREFORE, I, JOSEPH R. BIDEN JR., President of 
                the United States of America, by virtue of the 
                authority vested in me by the Constitution and the laws 
                of the United States, do hereby proclaim November 2023 
                as National Alzheimer's Disease Awareness Month. I call 
                on the people

[[Page 75456]]

                of the United States of America to honor and support 
                those living with Alzheimer's and the many people who 
                continue extraordinary and tireless efforts to combat 
                this disorder. I encourage all Americans to visit 
                www.Alzheimers.gov for evidence-based resources and 
                information.

                IN WITNESS WHEREOF, I have hereunto set my hand this 
                thirty-first day of October, in the year of our Lord 
                two thousand twenty-three, and of the Independence of 
                the United States of America the two hundred and forty-
                eighth.
                <GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
                
                    (Presidential Sig.)

[FR Doc. 2023-24488
Filed 11-2-23; 8:45 am]
Billing code 3395-F4-P